Cadile, Richard G.

HRN: 10-00-53  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2025
CEFTRIAXONE 1G (VIAL)
06/09/2025
06/16/2025
IV
1g
Q12
Biliary Cirrhosis Sec To Chronic Obstructive Jaundice Sec To Choledocholelithiasis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: